These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2501714)

  • 1. [Evaluation of the intestinal absorption of iron orally administered as chondroitin sulfate in normal subjects].
    Bergamaschi G; Carlo-Stella C; Pedrazzoli P; Carozzi A
    Minerva Med; 1989 May; 80(5):451-4. PubMed ID: 2501714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric chondroitin 6-sulfate (Condrofer): a new potent antianaemic agent with a favourable pharmacokinetic profile.
    Barone D; Orlando L; Vigna E; Baroni S; Borghi AM
    Drugs Exp Clin Res; 1988; 14 Suppl 1():1-14. PubMed ID: 3148451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.
    Adebowale A; Du J; Liang Z; Leslie JL; Eddington ND
    Biopharm Drug Dispos; 2002 Sep; 23(6):217-25. PubMed ID: 12214321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
    Du J; White N; Eddington ND
    Biopharm Drug Dispos; 2004 Apr; 25(3):109-16. PubMed ID: 15083499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability, absorption mechanism, and toxicity of microencapsulated iron (I) sulfate: studies in mice.
    Boccio JR; Zubillaga MB; Caro RA; Lysionek A; Gotelli CA; Gotelli MJ; Weill R
    Biol Trace Elem Res; 1998; 62(1-2):65-73. PubMed ID: 9630425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
    Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of exogenous chondroitin sulfate in the experimental animal.
    Palmieri L; Conte A; Giovannini L; Lualdi P; Ronca G
    Arzneimittelforschung; 1990 Mar; 40(3):319-23. PubMed ID: 2112001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1977 Apr; 72(15):654-9. PubMed ID: 853979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of partially depolymerized shark chondroitin sulfate in man.
    Ronca G; Conte A
    Int J Clin Pharmacol Res; 1993; 13 Suppl():27-34. PubMed ID: 7995679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of iron from grape-molasses and ferrous sulfate: a comparative study in normal subjects and subjects with iron deficiency anemia.
    Aslan Y; Erduran E; Mocan H; Gedik Y; Okten A; Soylu H; Değer O
    Turk J Pediatr; 1997; 39(4):465-71. PubMed ID: 9433148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration.
    Konador A; Kawiak J
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):895-903. PubMed ID: 612307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sideropenic anemia in patients under periodic hemodialysis treatment: efficacy and safety of oral iron treatment].
    Recchia G; Gulino S; Dean P; Prati G; Firpo M; Galvani E; Muolo A; Ancona G
    Clin Ter; 1984 Mar; 108(5):397-404. PubMed ID: 6232076
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N; Russell R
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
    Seid MH; Derman RJ; Baker JB; Banach W; Goldberg C; Rogers R
    Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1979 Nov; 74(48):1818-24. PubMed ID: 395435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.